Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

208.30
Delayed Data
As of Oct 28
 -3.85 / -1.81%
Today’s Change
192.32
Today|||52-Week Range
306.08
-4.86%
Year-to-Date
CRISPR Therapeutics Stock Falls 3.5% on Q3 Results
Oct 28 / MotleyFool.com - Paid Partner Content
Is Vertex Pharmaceuticals (VRTX) Outperforming Other Medical Stocks This Year?
Oct 20 / Zacks.com - Paid Partner Content
Can Coronavirus Vaccine Efforts Aid Novavax (NVAX) Q3 Earnings?
Oct 28 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Gets CHMP Nod for Forxiga in Heart Failure
Oct 20 / Zacks.com - Paid Partner Content
What's in Store for ADMA Biologics' (ADMA) Q3 Earnings?
Oct 28 / Zacks.com - Paid Partner Content
Endo (ENDP) Gains on Deal to Acquire BioSpecifics for $540M
Oct 20 / Zacks.com - Paid Partner Content
Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals
Oct 28 / MotleyFool.com - Paid Partner Content
Pick These 5 Stocks With Superb Interest Coverage Ratio
Oct 20 / Zacks.com - Paid Partner Content
Moderna (MRNA) to Report Q3 Earnings: What's in the Cards?
Oct 27 / Zacks.com - Paid Partner Content
Bet on These 5 Top-Ranked Stocks With Strong Sales Growth
Oct 20 / Zacks.com - Paid Partner Content
3 Biotech Stocks I'd Buy Right Now
Oct 27 / MotleyFool.com - Paid Partner Content
Vertex Pharmaceuticals (VRTX) Enters Oversold Territory
Oct 20 / Zacks.com - Paid Partner Content
Mattel, PLCE, Gilead, Vertex and Horizon as Zacks Bull and Bear of the Day
Oct 26 / Zacks.com - Paid Partner Content
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
Oct 19 / Zacks.com - Paid Partner Content
What's in the Cards for Cassava (SAVA) This Earnings Season?
Oct 26 / Zacks.com - Paid Partner Content
Gilead's (GILD) CAR T Cell Therapy Gets Positive CHMP Opinion
Oct 19 / Zacks.com - Paid Partner Content
Can Trikafta Drive Vertex's (VRTX) Revenues in Q3 Earnings?
Oct 26 / Zacks.com - Paid Partner Content
5 Big Pharma/Biotech Stocks Set to Trump Q3 Earnings Estimates
Oct 19 / Zacks.com - Paid Partner Content
Is CRISPR Therapeutics a Good Biotech Stock to Buy Now?
Oct 24 / MotleyFool.com - Paid Partner Content
Biogen (BIIB) to Report Q3 Earnings: What's in the Cards?
Oct 19 / Zacks.com - Paid Partner Content
Will Coronavirus Woes Affect Gilead's (GILD) Q3 Earnings?
Oct 23 / Zacks.com - Paid Partner Content
Lilly to Acquire Private Biotech for Boosting Pain Portfolio
Oct 16 / Zacks.com - Paid Partner Content
How Much Is Moderna Really Worth?
Oct 23 / MotleyFool.com - Paid Partner Content
Stock Market News for Oct 16, 2020
Oct 16 / Zacks.com - Paid Partner Content
CRISPR (CRSP) Falls Despite Positive Data on Lymphoma Study
Oct 22 / Zacks.com - Paid Partner Content
Forget Snowflake! 2 Hyper-Growth Stocks I'd Rather Buy
Oct 16 / MotleyFool.com - Paid Partner Content
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
Oct 22 / Zacks.com - Paid Partner Content
Tech Wrecks S&P 500: Most Stocks Gain Today, but Facebook, Other Tech Giants Crash the Party
Oct 15 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: BIIB Posts Q3 Results, VRTX Stops Study & Other Updates
Oct 22 / Zacks.com - Paid Partner Content
Why Arrowhead Pharmaceuticals Stock Jumped Today
Oct 15 / MotleyFool.com - Paid Partner Content
AstraZeneca's (AZN) Tagrisso sNDA Receives Priority Review
Oct 21 / Zacks.com - Paid Partner Content
Vertex Pulls Nasdaq Down, but Wall Street Loves Zoom
Oct 15 / MotleyFool.com - Paid Partner Content
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
Oct 21 / Zacks.com - Paid Partner Content
Vertex (VRTX) is an Incredible Growth Stock: 3 Reasons Why
Oct 15 / Zacks.com - Paid Partner Content
Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co
Oct 21 / Zacks.com - Paid Partner Content